1. Home
  2. AVXL vs THRM Comparison

AVXL vs THRM Comparison

Compare AVXL & THRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVXL
  • THRM
  • Stock Information
  • Founded
  • AVXL 2004
  • THRM 1991
  • Country
  • AVXL United States
  • THRM United States
  • Employees
  • AVXL N/A
  • THRM N/A
  • Industry
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • THRM Auto Parts:O.E.M.
  • Sector
  • AVXL Health Care
  • THRM Consumer Discretionary
  • Exchange
  • AVXL Nasdaq
  • THRM Nasdaq
  • Market Cap
  • AVXL 956.7M
  • THRM 997.7M
  • IPO Year
  • AVXL N/A
  • THRM 1993
  • Fundamental
  • Price
  • AVXL $9.95
  • THRM $35.04
  • Analyst Decision
  • AVXL Strong Buy
  • THRM Buy
  • Analyst Count
  • AVXL 2
  • THRM 3
  • Target Price
  • AVXL $44.00
  • THRM $46.00
  • AVG Volume (30 Days)
  • AVXL 1.2M
  • THRM 291.1K
  • Earning Date
  • AVXL 08-12-2025
  • THRM 07-24-2025
  • Dividend Yield
  • AVXL N/A
  • THRM N/A
  • EPS Growth
  • AVXL N/A
  • THRM N/A
  • EPS
  • AVXL N/A
  • THRM 1.02
  • Revenue
  • AVXL N/A
  • THRM $1,453,370,000.00
  • Revenue This Year
  • AVXL N/A
  • THRM $1.09
  • Revenue Next Year
  • AVXL N/A
  • THRM $3.26
  • P/E Ratio
  • AVXL N/A
  • THRM $34.83
  • Revenue Growth
  • AVXL N/A
  • THRM N/A
  • 52 Week Low
  • AVXL $4.93
  • THRM $22.75
  • 52 Week High
  • AVXL $14.44
  • THRM $52.06
  • Technical
  • Relative Strength Index (RSI)
  • AVXL 39.87
  • THRM 64.14
  • Support Level
  • AVXL $9.90
  • THRM $32.22
  • Resistance Level
  • AVXL $11.70
  • THRM $36.17
  • Average True Range (ATR)
  • AVXL 0.70
  • THRM 1.18
  • MACD
  • AVXL -0.23
  • THRM 0.14
  • Stochastic Oscillator
  • AVXL 1.62
  • THRM 78.19

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

About THRM Gentherm Inc

Gentherm Inc is an automotive parts manufacturer. The business activities of the group function through the Automotive and Medical segments. The vast majority of the firm's revenue comes from the Automotive segment, which includes automotive climate comfort systems, automotive cable systems, battery performance solutions, and automotive electronics and software systems. The medical segment is comprised of the results from the patient temperature management business in the medical industry. Its geographical segments are the United States, China, South Korea, Germany, Japan, the Czech Republic, and other countries.

Share on Social Networks: